Vega Surgical develops the Xcape port and Axis Drill to treat Chronic Subdural Hematomas (CSDHs) at the bedside, combining the effectiveness of traditional operating room procedures with the efficiency of bedside interventions. This approach addresses the high recurrence rate of nearly 30% associated with current bedside systems by providing a reliable method for CSDH evacuation through a minimally invasive opening.
Funding
$320K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic Subdural Hematomas (CSDHs) are commonly treated with either effective but inefficient operating room surgeries or convenient but less effective bedside procedures, leading to a high recurrence rate of nearly 30% with current bedside systems. Existing bedside systems often result in clogging and the need for reoperation due to inadequate evacuation.
Solution
Vega Surgical offers the Xcape port and Axis Drill system, designed to treat CSDHs at the bedside with the effectiveness of traditional operating room procedures. The Xcape device, implanted at the bedside using the Axis cranial access kit and drill, facilitates CSDH evacuation through an opening equivalent to a traditional burr hole. This approach aims to eliminate the frequent clogging and need for reoperation associated with currently available bedside systems, improving patient outcomes while decreasing costs. By combining the best attributes of both OR and bedside procedures, Vega Surgical provides a more reliable solution for CSDH treatment.
Target Audience
The primary target audience includes neurosurgeons and medical professionals treating Chronic Subdural Hematomas (CSDHs) in hospital and clinical settings.
Features
- Xcape port facilitates CSDH evacuation through an opening equivalent to a traditional burr hole.
- Axis Drill provides cranial access for bedside implantation of the Xcape port.
- Designed to reduce clogging and the need for reoperation compared to existing bedside systems.
- Aims to improve patient outcomes and decrease costs associated with CSDH treatment.